![Mark Lackner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lackner
Plus aucun poste en cours
Fortune : 779 260 $ au 31/08/2026
Profil
Mark Lackner worked at Genentech, Inc. from 2012 to 2018, serving as Director from 2015 to 2018.
From 2018 to 2022, worked at IDEAYA Biosciences, Inc. as SVP, Head-Biology & Translational Sciences.
From 2022 to 2025, worked at Zentalis Pharmaceuticals, Inc. as Chief Scientific Officer from 2023 to 2025.
Education includes a doctorate from Stanford University conferred in 1997, an undergraduate degree from the University of Illinois At Urbana–Champaign in 1990, and a graduate degree from the same institution in 1991.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 207 250 ( 0,22% ) | 779 260 $ | 31/08/2026 |
Anciens postes connus de Mark Lackner
| Sociétés | Poste | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2025 |
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/10/2022 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur/Membre du Conseil | 01/05/2018 |
Formation de Mark Lackner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
